Q: How do I define 'low-positive' versus 'high-positive' serology?

Low-positive is defined as RF or anti-CCP titers above the upper limit of normal but ≤3× the upper limit of normal. High-positive is >3× the upper limit of normal. If only qualitative results are available, use local lab thresholds.

Question 1

Can the 2010 criteria be used for established RA?

Accepted Answer

The criteria were designed and validated for early RA (symptom duration <2 years). In established RA with typical erosions, the clinical diagnosis is already clear and the criteria are unnecessary.

Question 2

How do I define 'low-positive' versus 'high-positive' serology?

Accepted Answer

Low-positive is defined as RF or anti-CCP titers above the upper limit of normal but ≤3× the upper limit of normal. High-positive is >3× the upper limit of normal. If only qualitative results are available, use local lab thresholds.

Question 3

Do the criteria apply to patients with previous DMARD therapy?

Accepted Answer

The criteria were validated in treatment-naïve patients. In patients already on DMARDs, joint counts may be suppressed, leading to underestimation. Document the pre-treatment clinical picture if available.

Question 4

What is the role of imaging in the criteria?

Accepted Answer

Imaging findings (ultrasound, MRI evidence of synovitis) are not formally part of the 2010 criteria. However, they can support the presence of joint involvement when physical examination is equivocal. Erosions typical of RA automatically establish the diagnosis.